about
Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulenceDemonstration of the phenomena of microbial persistence and reversion with bacterial L-forms in human embryonic kidney cellsPersisters-as elusive as everIndividuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiologyPhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosisWake me when it's over - Bacterial toxin-antitoxin proteins and induced dormancyRole of the vegetation in experimental Streptococcus viridans endocarditis.Why is long-term therapy required to cure tuberculosis?Replication dynamics of Mycobacterium tuberculosis in chronically infected miceSurvival of treponemes after treatment: comments, clinical conclusions, and recommendations.Infectivity tests in syphilis.Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteriaHost-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and diseaseLatent tuberculosis infection: myths, models, and molecular mechanismsPharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureusIdentification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation modelIntracellular Production of Brucella L Forms I. Recovery of L Forms from Tissue Culture Cells Infected with Brucella abortus.Effect of temperature on inoculum as a potential source of error in agar dilution plate count bactericidal measurementsHeterogeneous bacterial persisters and engineering approaches to eliminate them.THE NON-MEDICAL USE OF ANTIBIOTICS AND THE RISK OF CAUSING MICROBIAL DRUG-RESISTANCEEnumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis.Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae.Inapparent infection: relation of latent and dormant infections to microbial persistenceMetronidazole validates drugs targeting hypoxic bacteria for improved treatment of tuberculosisEPIDEMIOLOGY AND PATHOGENESIS OF STAPHYLOCOCCAL INFECTION. I. AN EXPERIMENTALLY INDUCED ATTENUATED STAPHYLOCOCCAL INFECTION IN GUINEA PIGS AND ITS MODIFICATION BY TETRACYCLINECORYNEBACTERIAL PSEUDOTUBERCULOSIS IN MICE. II. ACTIVATION OF NATURAL AND EXPERIMENTAL LATENT INFECTIONS.Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissuesMicrobial persistence. II. Characteristics of the sterile state of tubercle bacilliTHE TREATMENT OF BONE AND JOINT TUBERCULOSIS.The role of biomedical research in global tuberculosis control: gaps and challenges: A perspective from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health.Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in micePersistent bacterial infections, antibiotic tolerance, and the oxidative stress response.Functional relationship between bacterial cell density and the efficacy of antibiotics.Targeting persisters for tuberculosis controlThe normalcy of dormancy: common themes in microbial quiescencePersisters, persistent infections and the Yin-Yang model.Pathogenicity and virulence: another view.Phenotypic Resistance to Antibiotics.Pneumococcal type-associated variability in alternate complement pathway activation.Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method.
P2860
Q24544255-37094483-D801-496C-9935-3789C8261557Q24564357-C93A9A4B-A980-4BB5-BE96-3FA23CD947FFQ26748708-8B14FDBE-EBFC-4A03-B5EE-8659F4CCC704Q26775404-2798E432-4BA8-4605-B181-B8D9DE25D384Q28487517-6A87C0DF-C79D-46DF-AEDA-5D4AEFA0F41BQ28601184-B6DE1740-341B-412A-874A-CBC6C7E689BAQ30449483-B8363E08-A254-4AEB-AE97-F7A8B00ADD75Q33280142-7FD2E35F-EACE-4DA9-BFF3-732E7CBB5DE5Q33557117-FD91696E-2C84-4A13-B0F8-AC05B8B2298AQ33582904-5E7268FA-39DF-4069-9C32-795FE893C210Q33667536-6719432F-9D04-4819-801E-E6662009C643Q33716417-AD4004BE-1FF7-435B-9A5C-A9502191F8B5Q33925636-78B32575-DC1F-4194-873F-EFC45B54B5CEQ34297816-9722B3ED-2523-46FF-8386-E9A7F9E3748CQ34539889-1B9FA5CA-4D10-4E3A-8B18-233FEBA3A47CQ34881104-E4ABEAD5-2ED2-459D-B915-E34AF05833CDQ35174761-3911CF6D-6392-47DF-B3C4-49C157BCFFD0Q35299347-5FB619F6-9895-497F-B48E-D3C4638E5FE2Q35381988-4D139F17-0EA3-4CC2-9354-8766D69373AFQ35398977-ADC323B7-DD72-4FCC-95A6-19213ED3E311Q35651603-CE112112-AB87-4E1E-825C-4EAB0D45235FQ35842862-A3EB0DE4-5417-45DA-B733-4500B4BE0F9CQ35906698-B7E905D5-A017-4FE5-92AA-20B4982BD361Q36212780-169BD76E-4DC3-43AB-BA9F-874F5784C1BBQ36266527-E90A997C-2A4F-4F89-AB8F-15E4DA73E7FFQ36266603-A0B40970-D629-427A-9C5A-BB4691127119Q36268025-1021AA5A-0130-4D98-ACD3-053621263EF1Q36268037-2674B0F4-207F-4AEE-8C83-67355498D111Q36558934-ADD1350C-8C4C-412C-AF29-49FF6AE457A8Q36779704-0AB315FA-4F2C-4A2E-ABAE-0C132B74E726Q36991187-14F08F75-F833-4044-B7B9-2816F432ABF8Q37009017-EA07A290-11B2-454F-BB2A-E72DFDF62666Q37124158-F82E1671-A91E-4E9C-B129-626551D56564Q37990720-793F7473-2CBA-4909-AE56-FBF3AC436349Q38114535-C2485AAE-5FFB-479B-BD33-886B3F5AC04EQ38514259-60ECD1F1-3FEF-41DE-A119-D84630A605E7Q38596043-C04FA3DC-B33A-4E7C-8B5A-81256D161F76Q38793893-5891D28A-0C06-4983-9512-8D95C64DE9E3Q39063946-191CC4BF-4DAB-420C-B179-9D7A3486CB22Q39850270-5C8F6841-C9E3-4B35-A23E-A01FEEAFC857
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1958
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Microbial persistence.
@en
type
label
Microbial persistence.
@en
prefLabel
Microbial persistence.
@en
P2860
P1476
Microbial persistence
@en
P2093
McDERMOTT W
P2860
P304
P577
1958-02-01T00:00:00Z